If this is news to you, it may be because the $40 million earmarked for the project was buried in the One Big Beautiful Bill ...
Lantern Pharma Inc. , a clinical-stage biopharmaceutical company leveraging its proprietary RADR® artificial intelligence platform to transform oncology drug discovery and development, today announced ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results